Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia, and Mixed Vascular and Alzheimer’s Dementia

Depressive Syndrome Clinical Trial

Official title: Exploratory Study to Assess the Efficacy of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer’s Disease, Vascular Dementia and Mixed Vascular and Alzheimer’s Dementia

Status Unknown status

Clinical Trial Summary

The goal of the present study is to compare the effectiveness of the active (S)-enantiomer of citalopram, escitalopram with placebo in the treatment of patients with depressive syndrome complicating Alzheimer’s dementia (AD), vascular dementia (VD) or mixed dementia (MD), for 8 weeks of double-blind treatment.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Alzheimer Disease
• Dementia
• Dementia, Vascular
• Depressive Disorder
• Depressive Syndrome
• Syndrome
• Vascular Diseases

• NCT number: NCT00229333
• Study type: Interventional
• Source: Sheba Medical Center
• Contact: Anna Sverdlik, MD
• Phone: 972-54-4718424
• Email: annasver@hotmail.com
• Status: Unknown status
• Phase: Phase 4
• Start date: December 2004